Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$269,735
-$27,819 QoQ
Shares Held
2,135
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,732
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Texas Yale Capital Corp. holds $42,723,383 across 10 Drug Manufacturers - General names. GILD ranks #10 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
47,632 | $11,986,116 | |
| 2 | JNJ |
Johnson & Johnson
|
36,037 | $9,152,316 | |
| 3 | MRK |
Merck & Co., Inc.
|
58,713 | $7,544,620 | |
| 4 | LLY |
ELI LILLY & Co
|
5,751 | $6,897,922 | |
| 5 | AMGN |
Amgen Inc
|
10,322 | $3,737,802 | |
| 6 | NVO |
Novo Nordisk A S
|
22,899 | $1,097,778 | |
| 7 | BIIB |
Biogen Inc.
|
3,987 | $861,431 | |
| 8 | NVS |
Novartis AG
|
4,542 | $711,822 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $269,735 | 2,135 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $297,554 | 2,135 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $262,049 | 2,135 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $214,785 | 1,935 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $214,533 | 1,935 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $216,816 | 1,935 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||